Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-038885

EVP & Chief Commercial Officer sold 305 shares at $48.20 ($14,701)

From the SEC's structured data for this filing

Trades in this filing

Harris Erik · EVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-19 Sale : show line 1 in the form −305 $48.20 $14,701 57,281 D
Open-market sales · 305 sh · avg $48.20 · $14,701
Loading xslF345X04/doc4.xml…